Valuation: bioMérieux

Market Cap 10.54B 11.75B 9.74B 8.82B 16.49B 1,119B 16.69B 117B 46.4B 585B 44.08B 43.15B 1,859B P/E 2026 *
21.9x
P/E 2027 * 19.9x
Enterprise Value 10.13B 11.29B 9.36B 8.48B 15.84B 1,075B 16.03B 112B 44.59B 563B 42.36B 41.46B 1,786B EV / Sales 2026 *
2.45x
EV / Sales 2027 * 2.25x
Free-Float
33.22%
Yield 2026 *
1.18%
Yield 2027 * 1.3%
1 day+1.62%
1 week+5.51%
Current month+17.04%
1 month+14.18%
3 months+21.41%
6 months+30.37%
Current year-17.50%
1 week 86.45
Extreme 86.45
92.4
1 month 75.35
Extreme 75.35
92.4
Current year 65.6
Extreme 65.6
116.1
1 year 65.6
Extreme 65.6
116.1
3 years 65.6
Extreme 65.6
128.3
5 years 65.6
Extreme 65.6
133.2
10 years 42.68
Extreme 42.683332
144.8
Manager TitleAgeSince
Chief Executive Officer 53 2023-06-30
Director of Finance/CFO 50 2018-02-28
Chief Tech/Sci/R&D Officer - 2022-07-31
Director TitleAgeSince
Chairman 51 2017-12-14
Director/Board Member 66 2004-12-31
Director/Board Member 61 2012-05-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 Free

Chief Executive Officer

9,200 0.0078%
8/31/26 Free

Chief Technology Officer

1,203 0.0010%
8/31/26 Free

Chief Financial Officer

737 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+5.51%-19.75%+2.66% 11.74B
-0.26%+2.32%-18.77%+10.59% 178B
+1.08%+2.31%-19.01%+15.95% 116B
+1.37%+2.36%+2.15%+36.10% 115B
-2.26%+2.24%-44.03%+5.60% 93.1B
+0.10%-4.27%-2.90%+75.78% 62.09B
+0.17%+1.64%+8.50%+82.24% 55.87B
+0.03%+0.31%+5.82%-22.36% 53.12B
+0.98%+2.36%-10.69%+42.92% 44.22B
+0.10%+3.08%-3.06%-8.74% 33.59B
Average +0.31%+2.32%-10.17%+24.07% 76.28B
Weighted average by Cap. +0.16%+2.38%-12.59%+23.80%

Financials

2026 *2027 *
Net sales 4.13B 4.61B 3.82B 3.46B 6.47B 439B 6.55B 45.7B 18.2B 230B 17.29B 16.93B 729B 4.35B 4.85B 4.02B 3.64B 6.81B 462B 6.89B 48.1B 19.16B 242B 18.2B 17.82B 767B
Net income 486M 542M 449M 407M 760M 51.58B 769M 5.37B 2.14B 26.99B 2.03B 1.99B 85.68B 530M 591M 490M 444M 829M 56.26B 839M 5.86B 2.33B 29.44B 2.22B 2.17B 93.47B
Net Debt -412M -459M -381M -345M -645M -43.75B -653M -4.56B -1.81B -22.9B -1.72B -1.69B -72.68B -744M -829M -688M -623M -1.16B -78.97B -1.18B -8.22B -3.28B -41.32B -3.11B -3.05B -131B
Projected Income Statement - Annual - bioMérieux
Logo bioMérieux
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.3%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.7%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East /Africa (32.3%), North America (45.4%), Asia/Pacific (15.6%), and Latin America (6.7%).
Employees
14,894
Date Price Change Volume
26-10-28 €91.00 +1.62% 177,581
26-10-27 €89.55 +0.79% 98,057
26-10-26 €88.85 -0.39% 104,329
26-10-23 €89.20 +1.08% 166,304
26-10-22 €88.25 +2.32% 162,909
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - bioMérieux
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
89.55EUR
Average target price
80.61EUR
Spread / Average Target
-9.98%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - bioMérieux